Search

for
Search:

Research

5 / 1000+ results

research Enhancing dermatology clinical trials: optimizing sites and strategies for success in India

October 2025 in “International Journal of Clinical Trials”

This article highlights India's suitability as a strategic location for dermatology clinical trials due to its diverse patient population and cost-effective environment, offering insights on optimizing trials through advanced diagnostics, regulatory compliance, and ethical governance to attract global sponsors.

research Trichotillomania: Clinical Aspects and Treatment Strategies *

27 citations , March 1994 in “Harvard Review of Psychiatry”

This review discusses trichotillomania's clinical features, prevalence, and treatment options, highlighting the potential benefits of behavior therapy and pharmacotherapy but reports no new clinical findings.

research Use of priming strategies to advance the clinical application of mesenchymal stromal/stem cell-based therapy

16 citations , January 2024 in “World Journal of Stem Cells”

This review highlights the need for optimizing mesenchymal stromal/stem cell therapy through tailored in vitro strategies to unlock their full potential for treating specific diseases.

research Peculiarities of long-COVID-19 and treatment strategy: a clinical case

December 2021 in “Zenodo (CERN European Organization for Nuclear Research)”

This case report describes a post-COVID syndrome patient who experienced symptoms like headache, joint pain, and swollen lymph nodes; treatment with Erbisol drugs reportedly alleviated symptoms and normalized immunological parameters.

research Pharmacological Strategies for Mitigating Cytarabine-Induced Multi-Organ Toxicity: A Scoping Review on Mechanisms, Efficacy and Clinical Implications

June 2026 in “Cancers”

This scoping review identifies various pharmacological agents and five key mechanistic strategies being studied in vivo to mitigate multi-organ toxicity caused by cytarabine, with apraglutide and N-acetylcysteine highlighted as promising candidates for clinical application.

View more "clinical strategy" in research →

Community Join

5 / 1000+ results

community Hows the bro science feeling about 5mg oral min once a day or 2.5 twice?

4 upvotes 1 year ago

Oral minoxidil boosted vertex hair but not the hairline, with a stack including 5mg minoxidil, 2mg dutasteride, topical foam minoxidil, fluridil, and Nizoral. Users discuss dosing strategies, with some suggesting 2.5mg twice daily for sustained levels, while others recommend 5mg once daily based on clinical trials.

community Targeted Follicular Finasteride Delivery: A Low-Systemic Strategy

15 upvotes 5 months ago

A peptide-based delivery system for finasteride shows promise in reducing systemic side effects while maintaining hair growth effectiveness. Combining this with other treatments like minoxidil and RU58841 could enhance results with lower systemic absorption.

community Pp405 phase 2a clinical results

37 upvotes 1 year ago

PP405 shows initial promise for treating androgenetic alopecia, with safety confirmed in early trials, but skepticism remains due to limited data. Further trials are needed to determine its true efficacy and potential market impact.

community REVOLUTION in AUGUST: New possibilities according to Dr. Muñoz (pinacidil, cromakalim, diazoxide and nicorandil)

13 upvotes 1 year ago

Dr. Muñoz's discovery suggests that targeting potassium channels in fibroblasts could reactivate hair growth, offering new treatment possibilities for alopecia. Potential strategies include using minoxidil, diazoxide, and other potassium channel openers, as well as bioelectric devices and direct growth factor applications.

community Petition Alert: Let's Get PP405 Phase 3 Trials in Germany by 2026!

55 upvotes 1 year ago

A user is advocating for Phase 3 trials of the hair loss treatment PP405 to be conducted in Germany, citing benefits like a diverse patient base and faster access for European patients. Despite skepticism about the petition's influence, the user believes it can demonstrate significant interest and potentially influence strategic decisions.

View more "clinical strategy" in community →

Learn

10 / 801 results

learn Verteporfin

chemical that might completely regrow follicles from hair transplant extractions

learn Rapamycin

mTOR regulator and immunosuppressant used more recently for anti-aging and hair regrowth

learn Metformin

diabetes drug with anti-inflammatory, immunomodulatory, and insulin-sensitizing properties

learn Epidermal Growth Factor

learn Vascular Endothelial Growth Factor

learn KY19382

Are there clinical studies showing that KY19382 can regrow hair in androgenic alopecia? No clinical studies have proven KY19382 regrows hair in androgenic alopecia.

learn SCUBE3

What do clinical trials say about the safety and effectiveness of SCUBE3 for hair regrowth? No clinical trial of SCUBE3 for hair regrowth has been registered on ClinicalTrials.gov or published, so there is no human safety or effectiveness data. The evidence is limited to one 2022 laboratory and mouse study reporting that SCUBE3 activates hair follicle stem cells through TGF-beta signalling.

learn Follistatin

Are there any clinical studies supporting follistatin as a hair loss treatment? There is no controlled human trial showing follistatin treats hair loss; the published work is mouse and laboratory biology on the activin/follistatin signalling system, plus one small 2011 phase 1 injection study of a combination product, so follistatin remains experimental and unapproved.

learn Tofacitinib

What types of hair loss conditions are most commonly associated with tofacitinib use in clinical settings? Published studies link tofacitinib mainly to alopecia areata and its severe variants — as an off-label drug being studied for them, not as a cause of hair loss. The evidence is mostly small, open-label or retrospective, and relapse after stopping is commonly reported.

learn GT20029

When will GT20029 be commercially available, and are there any clinical trials on its use? GT20029 is not approved or commercially available anywhere and remains investigational. A published 12-week Phase II study in 180 Chinese men reports hair-count gains over placebo, but no long-term or Phase III data exists, so any launch is years away at best.

View more "clinical strategy" in learn →

Clinics

6 / 500 results

All 500 clinic results →

Experts

— no results

Try a deeper search in experts →